92 related articles for article (PubMed ID: 5294304)
1. Studies on attenuated measles-virus vaccines in Canada.
Nagler FP; Foley AR; Furesz J; Martineau G
Bull World Health Organ; 1965; 32(6):791-801. PubMed ID: 5294304
[TBL] [Abstract][Full Text] [Related]
2. WHO-supported comparative studies of attenuated live measles virus vaccines.
Cockburn WC; Pecenka J; Sundaresan T
Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
[TBL] [Abstract][Full Text] [Related]
3. Comparative trial of live measles vaccines in Czechoslovakia.
Syrůcek L; Helcl J; Sejda J; Svandová E; Staninec M; Grantová H; Mertenová J; Mílek E; Mirovský J; Procházka J; Strauss J; Zdrazílek J
Bull World Health Organ; 1965; 32(6):779-89. PubMed ID: 5294303
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of measles vaccines in a controlled trial in the USSR.
Bolotovskij VM; Nefedova LA; Gelikman BG; Zargaryants AT; Zetilova LP; Nastasina KT
Bull World Health Organ; 1966; 34(6):859-64. PubMed ID: 5296534
[TBL] [Abstract][Full Text] [Related]
5. A further study on measles vaccination in Nigerian children.
Hendrickse RG; Montefiore D; Sherman PM; Sofoluwe GO
Bull World Health Organ; 1965; 32(6):803-8. PubMed ID: 5294305
[TBL] [Abstract][Full Text] [Related]
6. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
[TBL] [Abstract][Full Text] [Related]
7. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
[TBL] [Abstract][Full Text] [Related]
8. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
[TBL] [Abstract][Full Text] [Related]
9. Controlled epidemiological study of live measles vaccines in Poland.
Polish Measles Vaccination Committee
Bull World Health Organ; 1971; 45(3):331-5. PubMed ID: 5316912
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of three measles vaccines in Indian children.
Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of four live measles vaccines in Israel.
Swartz T; Klingberg W; Nishmi M; Goldblum N; Gerichter C; Yofe Y; Cockburn WC
Bull World Health Organ; 1968; 39(2):285-92. PubMed ID: 5303410
[TBL] [Abstract][Full Text] [Related]
12. Trial of a reduced dose of measles vaccine in Nigerian children.
Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
14. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.
Kiepiela P; Coovadia HM; Loening WE; Coward P; Botha G; Hugo J; Becker PJ
Bull World Health Organ; 1991; 69(2):221-7. PubMed ID: 1860150
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the reaction-causing properties and the immunological and epidemiological effectiveness of Leningrad-16 and Schwarz live measles vaccines.
Bolotovskij VM; Zetilova LP
Bull World Health Organ; 1968; 39(2):293-8. PubMed ID: 4881072
[TBL] [Abstract][Full Text] [Related]
16. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
Weibel RE; Buynak EB; McLean AA; Hilleman MR
Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
[TBL] [Abstract][Full Text] [Related]
17. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
[TBL] [Abstract][Full Text] [Related]
18. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)].
Wiedermann G; Ambrosch F
Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537
[TBL] [Abstract][Full Text] [Related]
20. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]